nitroglycerin has been researched along with defibrotide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, N; Lefer, AM; Mulloy, D | 1 |
| Mantovani, M; Niada, R; Pescador, R; Porta, R; Prino, G | 1 |
| Di Nisio, M; Peinemann, F; Porreca, E; Rutjes, AW | 1 |
1 review(s) available for nitroglycerin and defibrotide
| Article | Year |
|---|---|
Treatment for superficial infusion thrombophlebitis of the upper extremity.
Topics: Anti-Inflammatory Agents; Anticoagulants; Catheterization, Peripheral; Dalteparin; Diclofenac; Drug Combinations; Drugs, Chinese Herbal; Escin; Gels; Heparin; Heparinoids; Humans; Ibuprofen; Nitroglycerin; Pentosan Sulfuric Polyester; Phospholipids; Polydeoxyribonucleotides; Randomized Controlled Trials as Topic; Thrombophlebitis; Upper Extremity | 2015 |
2 other study(ies) available for nitroglycerin and defibrotide
| Article | Year |
|---|---|
Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Male; Myocardial Reperfusion; Nitric Oxide; Nitroglycerin; Polydeoxyribonucleotides; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Superoxide Dismutase; Superoxides | 1990 |
Protective activity of defibrotide against lethal acute myocardial ischemia in the cat.
Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Epoprostenol; Heart Ventricles; Hemodynamics; Male; Nitroglycerin; Polydeoxyribonucleotides; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Ventricular Fibrillation | 1986 |